跳转至内容
Merck

Should butalbital-containing analgesics be banned? Yes.

Current pain and headache reports (2002-03-02)
William B Young, Hua Chiang Siow
摘要

In the United States analgesic-overuse headache is often caused by butalbital-containing analgesics. These agents can cause physical and psychological dependency, and dangerous withdrawal syndromes. Butalbital-containing analgesics have already been banned in several European countries. They are proven effective in tension-type headache, but not in migraine; there are many alternative treatments for migraine and tension-type headache. In the 20 years since analgesic overuse headache was widely recognized, butalbital overuse has remained distressingly common. It is time to ban these agents.

材料
货号
品牌
产品描述

Supelco
布他比妥标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®